GSK 269962A,
GSK-269962A,
GSK269962A,
N-(3-((2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo(4,5-c)pyridin-6-yl)oxy)phenyl)-4-((2-(4-morpholinyl)ethyl)oxy)benzamide,
GSK269962A,
850664-21-0,
GSK 269962,
GSK269962,
GSK 269962A,
GSK-269962A,
Aminofurazanyl-azabenzimidazole 6n,
925213-63-4,
GSK-269962,
N-(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-[2-(morpholin-4-yl)ethoxy]benzamide,
GSK269962A HCl,
Kinome_3843,
GSK269962A(GSK269962),
MLS006010261,
CHEMBL220241,
GTPL8037,
SCHEMBL1838346,
BDBM14047,
DTXSID40582496,
EX-A674,
YOVNFNXUCOWYSG-UHFFFAOYSA-N,
C29H30N8O5,
BCP27824,
3703AH,
ABP000268,
MFCD09970310,
ZINC14954335,
AKOS024457925,
BCP9000742,
CS-2790,
NCGC00241982-01,
NCGC00241982-03,
AK547999,
BC600782,
HY-15556,
SMR004701334,
GSK269962A/GSK 269962A,
GSK269962; GSK269962A,
LS-193319,
FT-0700376,
A12348,
AB01092223-01,
GSK 269962A;GSK-269962A;GSK269962;GSK 269962;GSK-269962,
N-(3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c] pyridin-6-yl]oxy}phenyl)-4-[2-(4-morpholinyl)ethoxy]benzamide,
N-(3-{[2-(4-amino-furazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-{[2-(4-morpholinyl)ethyl]oxy}benzamide,
N-[3-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]-benzamide,
N-[3-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]benzamide,
N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide,
N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide,
N-{3-[2-(4-Amino-furazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yloxy]-phenyl}-4-(2-morpholin-4-yl-ethoxy)-benzamide,
D02ZQS,
GSK269962B,
168828-81-7,